IGC shareholders elect directors, ratify auditor, approve 3M share grant

IGC Pharma, Inc.

Ram Mukunda, James Moran elected Class C directors until 2025; Claudia Grimaldi elected Class A director until 2023.
Ratified Manohar Chowdhry & Associates as independent auditor for fiscal 2023.
Approved grant of 3,000,000 common shares to employees, advisors, directors under performance/vesting metrics.
Total shares voted: 35,103,116 (67.40% of outstanding); broker non-votes 11,861,428.

item 5.02 item 5.07 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Ram Mukunda

Class C Director

IGC · IGC Pharma, Inc.

Effective: 2022-09-09
Filed: September 9, 2022, 7:59 PM ET

On September 9, 2022, Ram Mukunda and Congressman James Moran were elected to India Globalization Capital’s (the “Company”) Board of Directors at the 2022 Annual Meeting of Stockholders (the “Annual Meeting”), to serve as Class C directors, until the 2025 annual meeting of stockholders

Appointed

Claudia Grimaldi

Class A Director

IGC · IGC Pharma, Inc.

Effective: 2022-09-09
Filed: September 9, 2022, 7:59 PM ET

and Ms. Claudia Grimaldi was elected to the Company’s Board of Directors at the Annual Meeting, to serve as a Class A director, until the 2023 annual meeting of stockholders

Appointed

James Moran

Class C Director

IGC · IGC Pharma, Inc.

Effective: 2022-09-09
Filed: September 9, 2022, 7:59 PM ET

On September 9, 2022, Ram Mukunda and Congressman James Moran were elected to India Globalization Capital’s (the “Company”) Board of Directors at the 2022 Annual Meeting of Stockholders (the “Annual Meeting”), to serve as Class C directors, until the 2025 annual meeting of stockholders

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.8

Ram Mukunda was elected as Class C Director at IGC Pharma, Inc..

Action: elected
Role: Class C Director

Exact text from the filing

On September 9, 2022, Ram Mukunda and Congressman James Moran were elected to India Globalization Capital’s (the “Company”) Board of Directors at the 2022 Annual Meeting of Stockholders (the “Annual Meeting”), to serve as Class C directors, until the 2025 annual meeting of stockholders

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.8

Claudia Grimaldi was elected as Class A Director at IGC Pharma, Inc..

Action: elected
Role: Class A Director

Exact text from the filing

and Ms. Claudia Grimaldi was elected to the Company’s Board of Directors at the Annual Meeting, to serve as a Class A director, until the 2023 annual meeting of stockholders

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.8

James Moran was elected as Class C Director at IGC Pharma, Inc..

Action: elected
Role: Class C Director

Exact text from the filing

On September 9, 2022, Ram Mukunda and Congressman James Moran were elected to India Globalization Capital’s (the “Company”) Board of Directors at the 2022 Annual Meeting of Stockholders (the “Annual Meeting”), to serve as Class C directors, until the 2025 annual meeting of stockholders

View on SEC.gov

IGC Pharma, Inc. filing history →

Source: SEC EDGAR

accession 0001185185-22-001082

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.